Skandinaviska Enskilda Banken (SEB)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-347,671
| Closed | -$374M | – | 471 |
|
|
2025
Q4 | $374M | Sell |
347,671
-11,471
| -3% | -$11M | 1.5% | 9 |
|
|
2025
Q3 | $274M | Buy |
359,142
+30,128
| +9% | +$22.4M | 1.1% | 13 |
|
|
2025
Q2 | $256M | Buy |
329,014
+7,629
| +2% | +$5.93M | 1.12% | 13 |
|
|
2025
Q1 | $265M | Sell |
321,385
-15,214
| -5% | -$12.7M | 1.31% | 12 |
|
|
2024
Q4 | $260M | Buy |
336,599
+4,722
| +1% | +$3.91M | 1.18% | 14 |
|
|
2024
Q3 | $294M | Sell |
331,877
-2,405
| -0.7% | -$2.16M | 1.36% | 11 |
|
|
2024
Q2 | $303M | Sell |
334,282
-10,242
| -3% | -$8.19M | 1.45% | 9 |
|
|
2024
Q1 | $268M | Sell |
344,524
-1,925
| -0.6% | -$1.37M | 1.31% | 13 |
|
|
2023
Q4 | $202M | Sell |
346,449
-11,611
| -3% | -$6.78M | 1.17% | 13 |
|
|
2023
Q3 | $192M | Sell |
358,060
-2,854
| -0.8% | -$1.47M | 1.26% | 13 |
|
|
2023
Q2 | $169M | Buy |
360,914
+3,186
| +0.9% | +$1.34M | 1.11% | 14 |
|
|
2023
Q1 | $123M | Sell |
357,728
-15,517
| -4% | -$5.23M | 0.86% | 21 |
|
|
2022
Q4 | $137M | Sell |
373,245
-4,976
| -1% | -$1.76M | 1.03% | 12 |
|
|
2022
Q3 | $122M | Sell |
378,221
-82,463
| -18% | -$26.1M | 0.94% | 17 |
|
|
2022
Q2 | $149M | Buy |
460,684
+8,243
| +2% | +$2.47M | 1.1% | 12 |
|
|
2022
Q1 | $130M | Buy |
452,441
+5,389
| +1% | +$1.39M | 0.76% | 21 |
|
|
2021
Q4 | $124M | Sell |
447,052
-39,459
| -8% | -$10M | 0.64% | 30 |
|
|
2021
Q3 | $112M | Buy |
486,511
+11,062
| +2% | +$2.73M | 0.62% | 29 |
|
|
2021
Q2 | $109M | Sell |
475,449
-73,742
| -13% | -$14.8M | 0.67% | 23 |
|
|
2021
Q1 | $103M | Buy |
549,191
+12,815
| +2% | +$2.51M | 0.68% | 26 |
|
|
2020
Q4 | $90.6M | Sell |
536,376
-104,778
| -16% | -$15.6M | 0.62% | 25 |
|
|
2020
Q3 | $94.9M | Sell |
641,154
-3,027
| -0.5% | -$468K | 0.69% | 31 |
|
|
2020
Q2 | $106M | Sell |
644,181
-1,737
| -0.3% | -$267K | 0.85% | 20 |
|
|
2020
Q1 | $89.6M | Buy |
645,918
+196,916
| +44% | +$27.1M | 0.91% | 23 |
|
|
2019
Q4 | $59M | Buy |
449,002
+17,171
| +4% | +$1.99M | 0.46% | 51 |
|
|
2019
Q3 | $48.3M | Buy |
431,831
+19,743
| +5% | +$2.2M | 0.41% | 58 |
|
|
2019
Q2 | $45.7M | Sell |
412,088
-24,843
| -6% | -$2.93M | 0.39% | 63 |
|
|
2019
Q1 | $56.7M | Buy |
436,931
+60,063
| +16% | +$7.3M | 0.52% | 50 |
|
|
2018
Q4 | $43.6M | Sell |
376,868
-219,050
| -37% | -$24.5M | 0.39% | 56 |
|
|
2018
Q3 | $63.9M | Sell |
595,918
-213,400
| -26% | -$21.3M | 0.49% | 48 |
|
|
2018
Q2 | $69.1M | Buy |
809,318
+37,096
| +5% | +$3.05M | 0.59% | 43 |
|
|
2018
Q1 | $59.7M | Sell |
772,222
-56,071
| -7% | -$4.51M | 0.58% | 45 |
|
|
2017
Q4 | $70M | Buy |
828,293
+200,753
| +32% | +$17.1M | 0.6% | 44 |
|
|
2017
Q3 | $53.7M | Buy |
627,540
+454,385
| +262% | +$37.3M | 0.49% | 51 |
|
|
2017
Q2 | $14.3M | Buy |
173,155
+4,370
| +3% | +$357K | 0.14% | 146 |
|
|
2017
Q1 | $14.2M | Buy |
168,785
+741
| +0.4% | +$59.4K | 0.14% | 132 |
|
|
2016
Q4 | $12.4M | Sell |
168,044
-15,829
| -9% | -$1.18M | 0.15% | 119 |
|
|
2016
Q3 | $14.8M | Buy |
183,873
+5,153
| +3% | +$412K | 0.16% | 108 |
|
|
2016
Q2 | $14.1M | Buy |
178,720
+7,290
| +4% | +$549K | 0.16% | 103 |
|
|
2016
Q1 | $12.3M | Sell |
171,430
-1,719,494
| -91% | -$130M | 0.14% | 121 |
|
|
2015
Q4 | $159M | Buy |
+1,890,924
| New | +$157M | 2.06% | 13 |
|
Other funds holding LLY
Skandinaviska Enskilda Banken (SEB)'s LLY Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 347,671 shares — an estimated $374M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in LLY in Q4 2015 and held it in 41 quarters. The position peaked at $374M in Q4 2025. 4,378 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 347,671 Eli Lilly shares in Q1 2026, an estimated $374M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Eli Lilly in Q4 2015 and held it in 41 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Eli Lilly position peaked at $374M in Q4 2025.
- 4,378 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.